Blockbuster Inc. Company Profile

23:01 EST 23rd November 2017 | BioPortfolio

Blockbuster Inc. (NYSE: BBI, BBI.B) is a leading global provider of in-home movie and game entertainment, with more than 7,500 stores throughout the Americas, Europe, Asia and Australia. The company may be accessed worldwide at

News Articles [249 Associated News Articles listed on BioPortfolio]

The Startling History Behind Merck's New Cancer Blockbuster

The success of Merck’s blockbuster cancer drug pembrolizumab (Keytruda) was anything but inevitable. It was discovered accidentally, weathered two company acquisitions, and nearly out-licensed for ...

The blockbuster sex drug for women; creating a feminist issue

A thrice failed antidepressant is at the centre of a new marketing campaign to win approval for what could become the world’s first blockbuster sex pill for women. Frustrated by the drug’s repeate...

Remicade: Biosimilars And Pricing Pressure Wear On J&J's Blockbuster Brand

US sales were down 14%, but much of the hit was due to a 2016 price adjustment that was felt...   

Alexion Wins Expanded Approval for Blockbuster Drug Soliris

Alexion is set to secure even more revenue from its blockbuster drug Soliris, the most expensive drug in the world.

Celgene Plots Blockbuster Course For Ozanimod

Celgene, in need of good news, posted positive data on a potential blockbuster for multiple sclerosis at the joint ECTRIMS-ACTRIMS...   

China adds blockbuster drugs to insurance list after price cuts

SHANGHAI (Reuters) - China will add three dozen new drugs to a list of medicines covered by basic insurance schemes after global pharmaceutical firms agreed to slash prices of blockbuster treatments f...

News Headlines, PTV News: Feb 12, 2010

Gaucher rivals: Genzyme set to lose blockbuster monopoly Generics- no thanks: AstraZeneca chief bucks copy-cat trendGaucher rivals: Genzyme set to lose blockbuster monopoly[RELEASED 10:30 am GMT]

Welcome to the Blockbuster Club, Genmab!

Genmab has achieved $1B sales in the US of its blood cancer drug, Darzalex, setting a great example for other European biotechs to follow. Genmab has officially joined the elite of the biotech world ...

Drugs and Medications [0 Results]


PubMed Articles [5 Associated PubMed Articles listed on BioPortfolio]

The Next Blockbuster Drug?

Non-Covalent Immobilization of Molecular Electrocatalysts for Chemical Synthesis: Efficient Electrochemical Alcohol Oxidation with a Pyrene-TEMPO Conjugate.

Electrocatalytic methods for organic synthesis could offer sustainable alternatives to traditional redox reactions, but strategies are needed to enhance the performance of molecular catalysts designed...

Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine.

Chronic obstructive pulmonary disease (COPD) is a major cause of mortality worldwide, whose burden is expected to increase in the next decades, because of numerous risk factors, including the aging of...

Docking-based structural splicing and reassembly strategy to develop novel deazapurine derivatives as potent B-Raf(V600E) inhibitors.

The mutation of B-Raf(V600E) is widespread in a variety of human cancers. Its inhibitors vemurafenib and dabrafenib have been launched as drugs for treating unresectable melanoma, demonstrating that B...

Comparability study of Rituximab originator and follow-on biopharmaceutical.

Immunglobolin G (IgG)-based biopharmaceuticals are emerging on the pharmaceuticals market due to their high target selectivity in different diseases. In parallel, a growing interest by other companies...

Clinical Trials [0 Results]


Companies [23 Associated Companies listed on BioPortfolio]

Blockbuster Inc.

Blockbuster Inc. (NYSE: BBI, BBI.B) is a leading global provider of in-home movie and game entertainment, with more than 7,500 stores throughout the Americas, Europe, Asia and Australia. The company ...

Medical Marketing International Group plc

MMI is a “virtual” pharmaceutical development company focused on major therapeutic markets of current unmet need such as cancer and infectious disease.MMI harnesses the research productivi...

Vaxart, Inc.

Vaxart is a privately owned company developing oral recombinant vaccines based on its proprietary delivery platform. The Vaxart platform is suitable to deliver any protein vaccine...

Amgen Inc

Amgen is a leading human therapeutics company in the biotechnology industry. For 25 years, the company has tapped the power of scientific discovery and innovation to dramatically improve people’s li...

Aerie Pharmaceuticals, Inc.

Aerie Pharmaceuticals is a privately held pharmaceutical company in late Phase 2 dedicated to the discovery and development of novel small-molecule treatments for glaucoma. Aerie...

More Information about "Blockbuster Inc." on BioPortfolio

We have published hundreds of Blockbuster Inc. news stories on BioPortfolio along with dozens of Blockbuster Inc. Clinical Trials and PubMed Articles about Blockbuster Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Blockbuster Inc. Companies in our database. You can also find out about relevant Blockbuster Inc. Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record